Reporting owner · CIK 0001748691

Kaye Mark

SEC Form 4 history for the last 180 days across 1 company, 15 transactions and 2 filings.

EVP, CFOEVP & CFOElevance Health, Inc.
Open-market transaction mix0% buys0 buys · 13 sales

Period: Last 180 days

Trade dates in this period: Oct 2, 2026 – Oct 22, 2026

Transaction history, summary figures and purchase returns cover the last 180 days. Earlier activity is excluded from those sections.

Filings2Form 4 records
Buying$00 purchases
Selling$4.66M13 sales
Net value−$4.66MBuys minus sells · disclosed values

Latest insider transactions

Form 4 filings from the last 180 days.
Kaye Mark transactions · 20 per page
CompanyActivityDisclosed valueFiled (ET)
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$122kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$369kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$71.2kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$195kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$212kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$1.03MView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$758kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$510kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$105kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$245kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$724kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$140kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
SEC filing ↗
−$174kView disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
SEC filing ↗
$0View disclosure →
ELVElevance Health, Inc.
Executive Vice President · Chief Financial Officer
EVP, CFO
Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SEC filing ↗
−$1.61MView disclosure →

Latest Form 4 facts

Quick context from source filings

Latest open-market transaction

The insider reported a sale at Elevance Health, Inc. on Oct 22, 2026 valued at $122,082.87.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Monthly open-market activity

Last 1 reported month · purchases and sales

View exact monthly values
Monthly open-market source values
MonthPurchasesSalesBuy valueSale valueNet value
Oct 2026013$0$4,658,357.09−$4,658,357.09

Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.

Ownership and transaction size

Ownership and ticket size

Average P/S size$358k
Median P/S size$212k
Direct15
Indirect0
Oct 22, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
No open-market purchases in the last 180 days

A 90-day purchase return requires an open-market buy. None is recorded in the last 180 days. Purchases filed earlier are outside the visible history and are not included.

Disclosed ownership

How reported shareholdings evolved

Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.

15 observations · Oct 2, 2026 – Oct 22, 2026. Window ends at the latest available report, not today.

Selected observation · Oct 22, 202619,919 shares reported
Inspect transaction
View exact observations and source transactions
Transaction dateShares held afterFiledSource
Oct 2, 202627,876Oct 6, 2026View transaction
Oct 2, 202630,503Oct 6, 2026View transaction
Oct 22, 202630,103Oct 23, 2026View transaction
Oct 22, 202629,782Oct 23, 2026View transaction
Oct 22, 202628,122Oct 23, 2026View transaction
Oct 22, 202627,562Oct 23, 2026View transaction
Oct 22, 202627,322Oct 23, 2026View transaction
Oct 22, 202626,162Oct 23, 2026View transaction
Oct 22, 202624,442Oct 23, 2026View transaction
Oct 22, 202622,099Oct 23, 2026View transaction
Oct 22, 202621,619Oct 23, 2026View transaction
Oct 22, 202621,179Oct 23, 2026View transaction
Oct 22, 202621,019Oct 23, 2026View transaction
Oct 22, 202620,192Oct 23, 2026View transaction
Oct 22, 202619,919Oct 23, 2026View transaction

Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.

Kaye Mark Insider Activity FAQ

SEC Form 4 context

Who is Kaye Mark?

Kaye Mark is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001748691.

Which companies has Kaye Mark reported transactions for?

Elevance Health, Inc., CONMED Corp

When was Kaye Mark's latest insider buy?

No open-market insider purchase is recorded in the last 180 days. Earlier filings are outside the visible history.

When was Kaye Mark's latest insider sale?

The insider reported a sale at Elevance Health, Inc. on Oct 22, 2026 valued at $122,082.87.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.